Feasibility of resuming peritoneal dialysis after severe peritonitis and Tenckhoff catheter removal

Journal of the American Society of Nephrology

Volumn 13, Issue 4, 2002, Pages 1040-1045

  Szeto, Cheuk Chun ^a   Chow, Kai Ming ^a   Wong, Teresa Yuk Hwa ^a   Leung, Chi Bon ^a   Wang, Angela Yee Moon ^a   Lui, Siu Fai ^a   Li, Philip Kam Tao ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; CEPHALOSPORIN DERIVATIVE; NETILMICIN; VANCOMYCIN;

ADULT; AGED; AMBULATORY CARE; ANTIBIOTIC THERAPY; ARTICLE; CATHETER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIALYSATE; DISEASE SEVERITY; FEMALE; HEMODIALYSIS; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; PERITONEAL DIALYSIS; PERITONITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; SURVIVAL; TECHNIQUE; TREATMENT FAILURE; ULTRAFILTRATION;

EID: 0036205786     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Peritonitis as a complication of peritoneal dialysis
2. Challenges of managing chronic peritoneal dialysis-associated peritonitis
3. Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update
4. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update
5. Prevention and treatment of peritoneal dialysis membrane failure
6. Evaluation and management of ultrafiltration problems in peritoneal dialysis
7. Dialysis adequacy of Asian patients receiving small volume continuous ambulatory peritoneal dialysis
8. Importance of dialysis adequacy in mortality and morbidity of Chinese CAPD patients
9. The clinical course of Pseudomonas peritonitis complicating peritoneal dialysis - A review of 104 cases
10. Peritonitis during CAPD. A mixed bag
11. Xanthomonas maltophilia peritonitis in uremic patients receiving continuous ambulatory peritoneal dialysis
12. Peritoneal catheters and exit-site practices: Toward optimum peritoneal access
13. The impact of dialysis adequacy on the mortality and morbidity of anuric Chinese patients receiving continuous ambulatory peritoneal dialysis
14. Peritoneal equilibration test
15. Dialysate hyaluronan concentration predicts survival but not peritoneal sclerosis in continuous ambulatory peritoneal dialysis (CAPD)
16. Longitudinal study of peritoneal membrane function in CAPD: Relationship with peritonitis and fibrosing factors
17. The source and possible significance of hyaluronan in the peritoneal cavity
18. Synthesis of hyaluronic acid by human peritoneal mesothelial cells: Effect of cytokines and dialysate
19. The source of peritoneal proteoglycans: Human peritoneal mesothelial cells synthesise and secrete mainly small dermatan sulphate proteoglycans
20. Technique failure in peritoneal dialysis and its impact on patient survival
21. Prognostic factors in CAPD patients: A retrospective study of a 10 year period
22. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes
23. Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis
24. Survival advantage in Asian American end-stage renal disease patients